Skip to content

BEDALAB

Active Private limited companyfounded 1985active for 40 yearsVinkestraat 23, 8554 ZwevegemKBO/BCE: BE 0428.138.303

Lifetime

20 annual accounts with figures on one time axis, 40 filings since 1986
peak of €37,117 in 2007
€25,389▼ 2.3%
lowest -€10,468 in 2014
€18,495▲ 8.6%
peak of €173,957 in 2025
€173,957▲ 8.4%
€67,266▼ 3.2%
Board3 names since 2011
3 directors and 2 others
Owners
24.8%
Documentsfilings and deeds
20-07-202611 days before the deadline
2025abbreviated format
Cash from €51,318 to €68,180

Key points

from the 2025 annual accounts

Equity

€173,957 ▲ 8.4%

BEDALAB has made a profit without a break since 2018.

Turnover

≈ €130,000 estimated

The abbreviated format states no turnover.

Filings

40 annual accounts since 1986
AprilJune31 JulyOctober1990200020102020

Three of the last ten came late. The 2016 accounts came in latest, 30 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as BEDALAB has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for BEDALAB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Director,
Director,
  • 24.8%score equity €276,182 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0428138303
1 director appointed, 1 manager resigning, 2 reappointments resigns as manager · (director) and (director) reappointed · , and act as permanent representatives · General meeting of 13-11-2023 · Gazette deed
Capital increase of €75,000 to €93,592.01 The capital rose from €18,592.01 to €93,592.01, with 3,025 new shares · Gazette deed
Registered office moved from Kortrijk to Sint-Denijs The registered office moved from Groeningelaan 11 bus 12 te 8500 Kortrijk to Vinkestraat 23 te 8554 Sint-Denijs (Zwevegem) · appointed as manager · acts as permanent representative · General meeting of 18-12-2014 · Gazette deed
All 53 events

Comparable companies

same main activity, similar in size and age
Company
BEDALAB Zwevegem €241,224 €25,389 72.1% -
BORLOO Kortenberg €253,406 €22,834 90.7% -
INSTRUMA Lanaken €234,461 €16,408 66.1% -
CULOT ORTHOPEDIE La Louvière €168,989 €29,846 82.5% -
LIVAUDIO Tervuren €263,132 €47,472 14.4% -
FASCO Sint-Truiden €207,695 €23,327 62.0% -
CTO LIMBURG Kraainem €241,551 €42,253 66.0% -

These companies have the same main activity as BEDALAB: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €169,000 and €263,000, founded between 1982 and 1996.

Official details

Source: KBO
Status
Active since 10-12-1985Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Establishment unit
2.028.379.1738554 Zwevegem, registered on 10-12-1985
Financial year end
31 December
Peppol
Reachable since 07-12-2025
Company details

Annual accounts 2025

€241,224▲ 4.9%
Filing
Filed on 20-07-2026, 11 days before the end of the filing period
Financials

Insights on BEDALAB

BEDALAB files the abbreviated format. That format states no turnover. The gross margin rose from €17,859 in 2006 to €25,389 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BEDALAB

What is the company number of BEDALAB?
The company number of BEDALAB is 0428.138.303. The VAT number is the same number with BE in front: BE 0428.138.303.
Where is BEDALAB based?
The registered office is at Vinkestraat 23, 8554 Zwevegem.Company details
What does BEDALAB do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of BEDALAB?
BEDALAB is a private limited company (BV).
When was BEDALAB founded?
BEDALAB was founded on 10-12-1985.
Is BEDALAB still active?
Yes, BEDALAB is an active enterprise in the KBO register.
What is the turnover of BEDALAB?
The turnover in financial year 2025 is about €130,000. This figure is estimated from the gross margin of €25,389 and 34 comparable companies (NACE 464). It probably lies between €82,000 and €260,000.Financials
Is BEDALAB profitable?
In financial year 2025, BEDALAB made a profit of €18,495.
Where can I find the annual accounts of BEDALAB?
BEDALAB filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BEDALAB due?
BEDALAB must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.